NASDAQ:XERS | Profit Breakdown | Xeris Biopharma Holdings, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30$92.1M$5.17M-$31.1M
2026-03-31$83.13M$7.92M$2.23M
2025-12-31$85.81M$16.77M$11.08M
2025-09-30$74.38M$6.73M$621,000.00
2025-06-30$71.54M$4.48M-$1.93M
2025-03-31$60.12M-$3.09M-$9.22M
2024-12-31$60.1M$1.68M-$5.11M
2024-09-30$54.27M-$12.89M-$15.74M
2024-06-30$48.07M-$8.19M-$15.01M
2024-03-31$40.64M-$14.25M-$18.98M
2023-12-31$44.39M-$9.84M-$13.39M
2023-09-30$48.32M-$4.91M-$12.19M
2023-06-30$38.01M-$15.98M-$19.84M
2023-03-31$33.2M-$13.28M-$16.83M
2022-12-31$33.14M-$15.17M-$12.93M
2022-09-30$29.73M-$18.78M-$21.83M
2022-06-30$25.31M-$18.92M-$26.19M
2022-03-31$22.07M-$29.07M-$33.71M
2021-12-31$21.43M-$48.27M-$50.79M
2021-09-30$11.06M$7.84M-$24.36M-$26.01M
2021-06-30$8.91M-$25.79M-$27.52M
2021-03-31$8.05M-$16.74M-$18.41M
2020-12-31$7.09M-$19.34M-$21.86M
2020-09-30$9.4M$6.62M-$13.74M-$16M
2020-06-30-$24.1M
2020-03-31-$29.18M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31$291.85M$24.9M$554,000.00$554,000.00
2024-12-31$203.07M-$33.65M-$57.1M-$54.84M
2023-12-31$163.91M-$44.01M-$63.5M-$62.26M
2022-12-31$110.25M-$81.94M-$96.08M-$94.66M
2021-12-31$49.59M-$115.16M-$122.73M-$122.73M
2020-12-31$20.16M-$83.55M-$91.14M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.